| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/04/2013 | CN103417482A TNP-470 (O-(chloroacetyl-carbamoyl)fumagillol) loaded slow-release nanoparticle and preparation method and application thereof |
| 12/04/2013 | CN103417480A Novel polypeptide modified tumor targeted liposome of targeted integrin receptor |
| 12/04/2013 | CN103417479A Ginsenoside Rg3 liposome and preparation method thereof |
| 12/04/2013 | CN103417478A Water based ivermectin O/W injection and preparation method thereof |
| 12/04/2013 | CN103417477A Doramectin O/W type injection taking water as matrix and preparation method thereof |
| 12/04/2013 | CN103417475A Barusiban injection and preparation method thereof |
| 12/04/2013 | CN103417474A Calcium dibutyacyladenosine cyclophosphate-containing composition for injection |
| 12/04/2013 | CN103417473A Adapalene gel and method for preparing same |
| 12/04/2013 | CN103417472A Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| 12/04/2013 | CN103417469A Novel implant |
| 12/04/2013 | CN103417468A 一种依托泊苷植入剂 One kind of etoposide implants |
| 12/04/2013 | CN103417467A Dexamethasone implant |
| 12/04/2013 | CN103417191A Multifunctional Raman probe with detection, hyperthermia and chemotherapy properties |
| 12/04/2013 | CN103416598A Preparation method of micro-encapsulation coated yolk derived cholecystokinin antibodies |
| 12/04/2013 | CN102805728B Propofol fat emulsion injection and preparation method thereof |
| 12/04/2013 | CN102698279B Preparation method of amphipathic gama-polyglutanmic acid nanodrug carrier |
| 12/04/2013 | CN102671625B Method for preparing graphene magnetic nanometer composite materials |
| 12/04/2013 | CN102670526B 奥沙利铂冻干粉针剂及其制备方法 Oxaliplatin freeze-dried powder and its preparation method |
| 12/04/2013 | CN102641320B Gynaecological effervescent tablet and preparation method thereof |
| 12/04/2013 | CN102626488B Gastrodia elata medicine for treating insomnia |
| 12/04/2013 | CN102600089B Medicine composition containing raltitrexed and preparation method of medicine composition |
| 12/04/2013 | CN102585012B Preparation method for grouper alpha interferon derivative and application |
| 12/04/2013 | CN102579353B Pegylated liposome of folate-targeted anticancer drug and preparation method |
| 12/04/2013 | CN102552323B Medicine for accelerating skin repair and regeneration, preparation method thereof and application thereof |
| 12/04/2013 | CN102462672B Ramosetron transdermal patch and preparation method thereof |
| 12/04/2013 | CN102399369B Method for preparing supramolecular polymer micelle drug carriers sensitive to amino acid |
| 12/04/2013 | CN102399293B Recombinant protein specifically bound with fibrin and application thereof |
| 12/04/2013 | CN102327232B Preparation method of granular premixing agent |
| 12/04/2013 | CN102228511B Soft capsule for treating cardiovascular diseases and preparation method thereof |
| 12/04/2013 | CN102206333B Low molecular weight polycarbonate polyatomic alcohol and preparation method and application thereof |
| 12/04/2013 | CN102089009B Conjugated Vi saccharides |
| 12/04/2013 | CN101951958B Cholesterol derivatives of inhibitors of viral fusion |
| 12/04/2013 | CN101862326B Medicine compound containing febuxostat |
| 12/04/2013 | CN101862325B Medicine compound containing candesartan cilexetil |
| 12/04/2013 | CN101687043B Coated oral nicotine formulation buffered with amino acid |
| 12/04/2013 | CN101636150B Method for producing pulverized organic compound particle |
| 12/04/2013 | CN101137673B Cripto结合分子 Cripto binding molecules |
| 12/03/2013 | US8600494 Method and device for treating abnormal tissue growth with electrical therapy |
| 12/03/2013 | US8598324 Anti-pathogen treatments |
| 12/03/2013 | US8598316 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies |
| 12/03/2013 | US8598269 Antimicrobial constructs |
| 12/03/2013 | US8598236 Emulsion system derived from engkabang fat esters |
| 12/03/2013 | US8598218 Liquid pharmaceutical formulations of palonosetron |
| 12/03/2013 | US8598112 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| 12/03/2013 | US8597682 Method for manufacturing mesoporous materials, materials so produced and use of mesoporous materials |
| 12/03/2013 | US8597677 Compositions and methods for controlling the weight of animals |
| 12/03/2013 | US8597665 Chimeric immunomodulatory compounds and methods of using the same-IV |
| 12/03/2013 | US8597630 Thermal-responsive polymer networks, compositions, and methods and applications related thereto |
| 12/03/2013 | US8597629 Artificial tear compositions comprising a combination of nonionic surfactants |
| 12/03/2013 | US8597619 Thickener or gellant for oil materials, gel composition comprising same, and method of producing cosmetic material or topical agent |
| 12/03/2013 | CA2702604C Transdermal drug delivery using an osmolyte and vasoactive agent |
| 12/03/2013 | CA2684165C Oligonucleotide-prolyethylene glycol compound |
| 12/03/2013 | CA2637408C Foam-forming composition |
| 12/03/2013 | CA2602396C Alkyl sulfate free and orthophosphate free dentifrice composition comprising a fluoride source and a silica dental abrasive |
| 12/03/2013 | CA2572057C A photoactive biocompatible coating composition |
| 12/03/2013 | CA2566481C Peptides or peptidic conjugate derivatives of msh and the use thereof for cosmetically fighting against canities |
| 12/03/2013 | CA2565382C Use of a viscoelastic composition for treating increased intraocular pressure |
| 12/03/2013 | CA2463017C Method for preparation of single chain antibodies |
| 12/03/2013 | CA2449426C Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 12/03/2013 | CA2240834C Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| 11/30/2013 | CA2817260A1 Microspheres including oxidized cellulose |
| 11/30/2013 | CA2817259A1 Microspheres including oxidized cellulose |
| 11/30/2013 | CA2795550A1 Solid dosage formulations of an orexin receptor antagonist |
| 11/30/2013 | CA2790763A1 Aptamer bioconjugate drug delivery device |
| 11/30/2013 | CA2778735A1 Induction of arteriogenesis |
| 11/30/2013 | CA2778679A1 Use of stabilized granules containing glyceryl trinitrate for arteriogenesis |
| 11/28/2013 | WO2013177481A1 Benzodiazepines and conjugates thereof |
| 11/28/2013 | WO2013177415A1 Lipid nanoparticle compositions for antisense oligonucleotides delivery |
| 11/28/2013 | WO2013177397A1 Multivalent meningococcal conjugates and methods for preparing cojugates |
| 11/28/2013 | WO2013177104A2 Treatment for tauopathies |
| 11/28/2013 | WO2013177063A1 Uses of protein precursors as prodrugs |
| 11/28/2013 | WO2013177062A2 Methods for improving safety of blood-brain barrier transport |
| 11/28/2013 | WO2013177055A2 ANTI-Ly6E ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE |
| 11/28/2013 | WO2013176522A1 Method for synthesizing radiopharmaceuticals using a cartridge |
| 11/28/2013 | WO2013176516A1 Antibody-drug conjugate prepared by using transglutaminase and use thereof |
| 11/28/2013 | WO2013176468A1 Liver targeted drug delivery systems using metal nanoparticles and preparing method thereof |
| 11/28/2013 | WO2013176455A1 Multilayer coating form of orally administered pharmaceutical composition containing omega-3 fatty acid or alkyl ester thereof and statin based drug |
| 11/28/2013 | WO2013176375A1 Temperature-sensitive anti-adhesive material |
| 11/28/2013 | WO2013176243A1 Lecithin organogel formation agent |
| 11/28/2013 | WO2013175781A1 Pharmaceutical composition for inhalation |
| 11/28/2013 | WO2013175385A1 Bisphosphonates vinylic monomers and polymers and uses thereof |
| 11/28/2013 | WO2013175303A1 Acid resistant banding solution for two piece hard capsules |
| 11/28/2013 | WO2013174978A1 Somatostatin receptor agonist formulations |
| 11/28/2013 | WO2013174936A1 Aqueous pharmaceutical composition containing a biologic therapeutic agent and guanidine or a guanidine derivative and an injection including the composition |
| 11/28/2013 | WO2013174884A1 Capsules having an incorporated taste modifying component |
| 11/28/2013 | WO2013174883A1 Compositions comprising short-acting benzodiazepines |
| 11/28/2013 | WO2013174832A1 Meningococcus serogroup x conjugate |
| 11/28/2013 | WO2013174498A1 Dosage forms comprising apixaban and matrix former |
| 11/28/2013 | WO2013174409A1 Reversible immobilization and/or controlled release of nucleic acid containing nanoparticles by (biodegradable) polymer coatings |
| 11/28/2013 | WO2013131089A3 Potent anticancer activity via dual compound activation |
| 11/28/2013 | WO2013128201A3 Structured silicon particles |
| 11/28/2013 | WO2013126550A3 Antimicrobial compositions, the preparation and use thereof |
| 11/28/2013 | WO2012118729A3 Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
| 11/28/2013 | US20130317462 Transdermal delivery system for hormones and steroids |
| 11/28/2013 | US20130317121 Method for the preparation of plymers with varied archtecture and amide initiation |
| 11/28/2013 | US20130317120 Functionalized non-phenolic amino acids and absorbable polymers therefrom |
| 11/28/2013 | US20130317117 Self micro-emulsifying drug delivery system with increased bioavailability |
| 11/28/2013 | US20130317111 Desensitizing drug product |
| 11/28/2013 | US20130317098 Protective hydrocolloid for active ingredients |
| 11/28/2013 | US20130317097 Stable compositions of dehydroascorbic acid |